Geneplus Technology

Beijing, China · Founded 2015 · In IPO Registration

Provider of gene sequencing and detection services intended for hospitals, research institutions, and pharmaceutical companies. Geneplus Technology is based in Beijing, China and was founded in 2015. Its last reported valuation was $605 million in Nov 2025. It has raised $186 million.

Last reported valuation
$604.6M
Oct 2026
Priced at
—
Total raised
$186.1M
Last round
—

Who backs Geneplus Technology?

27 investors
InvestorType
Fortune CapitalVenture capital
Co-Stone CapitalPE / buyout
Green Pine Capital PartnersVenture capital
Baidu VenturesOther
Highlight CapitalOther
Granite AsiaVenture capital
Zhongguancun Development Venture Capital FundOther
Huatai Zijin InvestmentOther
CCB InternationalPE / buyout
Chang DevelopmentOther
+ 17 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Geneplus Technology investors

27 investors are on record for Geneplus Technology, including Fortune Capital, Co-Stone Capital, Green Pine Capital Partners and Baidu Ventures. By type, the record holds 3 venture capital firms and 2 private equity firms.

Free account
More of Geneplus Technology with a free account
  • ·The complete investor list: 27 names
  • ·Watch Geneplus Technology: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 27 firms already write checks for companies like Geneplus Technology. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View